244 related articles for article (PubMed ID: 33558459)
21. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
[No Abstract] [Full Text] [Related]
22. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
23. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia.
Qu M; Wang J; Chen DC; Chen S; Xiu MH; Zhang XY
Free Radic Biol Med; 2020 Nov; 160():887-893. PubMed ID: 32949664
[TBL] [Abstract][Full Text] [Related]
24. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
25. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
[TBL] [Abstract][Full Text] [Related]
26. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
Green MJ; Matheson SL; Shepherd A; Weickert CS; Carr VJ
Mol Psychiatry; 2011 Sep; 16(9):960-72. PubMed ID: 20733577
[TBL] [Abstract][Full Text] [Related]
27. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
28. TGF-β1 is associated with deficits in cognition and cerebral cortical thickness in first-episode schizophrenia.
Pan S; Zhou Y; Yan L; Xuan F; Tong J; Li Y; Huang J; Feng W; Chen S; Cui Y; Yang F; Tan S; Wang Z; Tian B; Hong LE; Tan YL; Tian L
J Psychiatry Neurosci; 2022; 47(2):E86-E98. PubMed ID: 35301253
[TBL] [Abstract][Full Text] [Related]
29. Associations between cognition and white matter microstructure in first-episode antipsychotic-naïve patients with schizophrenia and healthy controls: A multivariate pattern analysis.
Thomas MB; Raghava JM; Pantelis C; Rostrup E; Nielsen MØ; Jensen MH; Glenthøj BY; Mandl RCW; Ebdrup BH; Fagerlund B
Cortex; 2021 Jun; 139():282-297. PubMed ID: 33933719
[TBL] [Abstract][Full Text] [Related]
30. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
31. BDNF Polymorphisms Are Associated With Cognitive Performance in Schizophrenia Patients Versus Healthy Controls.
Zhang XY; Chen da C; Tan YL; Tan S; Luo X; Zuo L; Soares JC
J Clin Psychiatry; 2016 Aug; 77(8):e1011-8. PubMed ID: 27561148
[TBL] [Abstract][Full Text] [Related]
32. Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia.
Luckhoff HK; Kilian S; Olivier MR; Phahladira L; Scheffler F; du Plessis S; Chiliza B; Asmal L; Emsley R
Metab Brain Dis; 2019 Apr; 34(2):469-476. PubMed ID: 30604027
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
34. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
[TBL] [Abstract][Full Text] [Related]
35. Sex difference in cognitive impairment in drug-free schizophrenia: Association with miR-195 levels.
Huang X; Bao C; Lv Q; Zhao J; Wang Y; Lang X; Li Z; Yi Z
Psychoneuroendocrinology; 2020 Sep; 119():104748. PubMed ID: 32559610
[TBL] [Abstract][Full Text] [Related]
36. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
[TBL] [Abstract][Full Text] [Related]
37. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
[TBL] [Abstract][Full Text] [Related]
38. The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia.
Kim SJ; Jung D; Shim JC; Moon JJ; Jeon DW; Kim YN; Seo YS; Jung SS; Seo BJ; Kim JE
Asian J Psychiatr; 2019 Dec; 46():111-117. PubMed ID: 31654923
[TBL] [Abstract][Full Text] [Related]
39. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol prevents cognitive deficits induced by chronic unpredictable mild stress: Sirt1/miR-134 signalling pathway regulates CREB/BDNF expression in hippocampus in vivo and in vitro.
Shen J; Xu L; Qu C; Sun H; Zhang J
Behav Brain Res; 2018 Sep; 349():1-7. PubMed ID: 29715537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
